Vir Bio Ownership | Who Owns Vir Bio?

Overview Forecast RevenueFinancials Chart Transcripts

Vir Bio Ownership Summary

Vir Bio is owned by 48.77% institutional investors, 11.90% insiders, and 39.33% retail investors. Sb investment advisers (uk) is the largest institutional shareholder, holding 12.33% of VIR shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.24% of its assets in Vir Bio shares.

VIR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Vir Bio	48.77%	11.90%	39.33%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Sb investment advisers (uk)	16.68M	12.33%	$148.49M
Blackrock	16.43M	12.15%	$146.26M
Blackrock funding, inc. /de	16.46M	12.05%	$120.84M
Vanguard group	13.13M	9.61%	$96.38M
State street	5.09M	3.77%	$45.34M
Orbimed advisors	3.22M	2.36%	$23.62M
Geode capital management	2.20M	1.61%	$16.13M
Morgan stanley	2.12M	1.57%	$18.90M
Dimensional fund advisors lp	1.92M	1.40%	$14.06M
Jpmorgan chase	1.81M	1.32%	$13.26M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bill & melinda gates foundation	1.56M	23.22%	$13.88M
Sio capital management	1.05M	2.18%	$7.74M
Sb investment advisers (uk)	16.68M	1.37%	$148.49M
Stonepine capital management	164.11K	0.97%	$1.20M
Ikarian capital	897.86K	0.90%	$6.59M
Sphera funds management	581.83K	0.77%	$4.27M
Orbimed advisors	3.22M	0.49%	$23.62M
Tejara capital	51.97K	0.25%	$381.44K
Dafna capital management	100.00K	0.19%	$734.00K
Adar1 capital management	64.07K	0.09%	$470.25K

Top Buyers

Holder	Shares	% Assets	Change
Baker bros. advisors lp	1.08M	0.09%	1.08M
Sio capital management	1.05M	2.18%	1.05M
Artisan partners limited partnership	918.53K	0.01%	918.53K
Ikarian capital	897.86K	0.90%	897.86K
Point72 asset management	848.45K	0.01%	843.24K

Top Sellers

Holder	Shares	% Assets	Change
Baillie gifford	-	-	-2.38M
State street	5.09M	0.00%	-1.97M
D. e. shaw	502.00K	0.00%	-428.65K
Orbimed advisors	3.22M	0.49%	-354.38K
Barclays	221.18K	0.00%	-329.01K

New Positions

Holder	Shares	% Assets	Change	Value
Baker bros. advisors lp	1.08M	0.09%	1.08M	$7.96M
Sio capital management	1.05M	2.18%	1.05M	$7.74M
Artisan partners limited partnership	918.53K	0.01%	918.53K	$6.74M
Ikarian capital	897.86K	0.90%	897.86K	$6.59M
Abrdn	363.16K	0.01%	363.16K	$2.67M

Sold Out

Holder	Change
Northwestern mutual wealth management	-5.00
Mendota financial group	-6.00
Dinuzzo private wealth	-6.00
Sjs investment consulting	-12.00
Nelson, van denburg & campbell wealth management group	-16.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	204	-0.49%	66,639,809	-23.94%	48	1.19%	106	8.16%	64	-5.88%
Sep 30, 2024	204	-5.99%	87,613,923	-0.48%	64	1.54%	99	-11.61%	68	-2.86%
Jun 30, 2024	214	0.94%	88,011,508	-0.80%	65	1.50%	110	6.80%	70	9.38%
Mar 31, 2024	212	1.44%	88,721,860	0.71%	65	1.53%	103	1.98%	64	-7.25%
Dec 31, 2023	209	-2.34%	88,094,029	1.19%	65	1.56%	101	-24.63%	69	35.29%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	5.82M	4.24%	4.03K
Scottish Mortgage Ord	3.80M	2.78%	-
Vanguard US Total Market Shares ETF	3.46M	2.52%	-
Vanguard Total Stock Mkt Idx Inv	3.44M	2.51%	-
Vanguard Small Cap Index	2.81M	2.05%	2.29K
iShares Russell 2000 ETF	2.39M	1.74%	-20.73K
SPDR® S&P Biotech ETF	2.10M	1.53%	-22.46K
Vanguard Small Cap Growth Index Inv	1.57M	1.15%	-10.96K
Vanguard Institutional Extnd Mkt Idx Tr	1.39M	1.01%	26.57K
Biotech Growth Ord	1.20M	0.87%	-23.20K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 03, 2025	De Backer Marianne	Chief Executive Officer	Sell	$474.24K
Feb 26, 2025	de Verneuil Vanina	EVP and General Counsel	Sell	$67.40K
Feb 24, 2025	SCANGOS GEORGE A	-	Sell	$95.06K
Feb 24, 2025	HANLY ANN M.	EVP & Chief Technology Officer	Sell	$133.94K
Feb 24, 2025	Sabatini Brent	SVP, Chief Accounting Officer	Sell	$14.77K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	9
2024 Q4	-	4
2024 Q3	-	1
2024 Q2	-	3
2024 Q1	-	8

VIR Ownership FAQ

Who Owns Vir Bio?

Vir Bio shareholders are primarily institutional investors at 48.77%, followed by 11.90% insiders and 39.33% retail investors. The average institutional ownership in Vir Bio's industry, Biotech Stocks , is 68.48%, which Vir Bio falls below.

Who owns the most shares of Vir Bio?

Vir Bio’s largest shareholders are Sb investment advisers (uk) (16.68M shares, 12.33%), Blackrock (16.43M shares, 12.15%), and Blackrock funding, inc. /de (16.46M shares, 12.05%). Together, they hold 36.53% of Vir Bio’s total shares outstanding.

Does Blackrock own Vir Bio?

Yes, BlackRock owns 12.15% of Vir Bio, totaling 16.43M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 146.26M$. In the last quarter, BlackRock decreased its holdings by -129K shares, a -0.78% change.

Who is Vir Bio’s biggest shareholder by percentage of total assets invested?

Bill & melinda gates foundation is Vir Bio’s biggest shareholder by percentage of total assets invested, with 23.22% of its assets in 1.56M Vir Bio shares, valued at 13.88M$.

Who is the top mutual fund holder of Vir Bio shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Vir Bio shares, with 4.24% of its total shares outstanding invested in 5.82M Vir Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools